People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Hemobiotech, Inc. | — | Pharmaceuticals | Seed | $3.7M | $7.6M | 2009 |
Robert P. Comer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert P. Comer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Baron | 1 | 4 |
| Arthur P. Bollon | 1 | 2 |
| Bernhard Mittemeyer | 1 | 1 |
| Ghassan Nino | 1 | 1 |
| Robert Dragoo, Jr. | 1 | 1 |
| Arthur Bollon | 1 | 1 |
| Mario P. Feola | 1 | 1 |
| Robert P. Dragoo | 1 | 1 |
| Mark P. Rosenblum | 1 | 1 |
| Robert P. Baron | 1 | 1 |
| Ghassan P. Nino | 1 | 1 |
| Bernard P. Mittemeyer | 1 | 1 |
| Jan P. Simoni | 1 | 1 |
| Robert Comer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.